Sunday’s Midday Stock Update: Rite Aid (RAD), Whiting Petroleum (WLL), Exelixis (EXEL), Agios Pharma (AGIO), American Airlines (AAL)

So far Sunday, December 29, NASDAQ is down -3.62% and the S&P is down -0.88%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Rite Aid (RADResearch Report), Whiting Petroleum (WLLResearch Report), Exelixis (EXELResearch Report), Agios Pharma (AGIOResearch Report) and American Airlines (AALResearch Report).

Rite Aid is down -7.64% in midday trading to $20.30. Shares opened today at $21.98. The company has a 52-week low of $5.04 and a 52-week high of $23.88. On the Street’s front, the average 12-month analyst price target for the stock is $12.00, marking a -45.40% potential downside from current levels. In a report issued on December 23, Deutsche Bank analyst George Hill maintained a Sell rating on RAD, with a price target of $12.00, which represents a potential downside of 45% from where the stock is currently trading. In the last 30 days, insiders have sold $31.04K worth of RAD shares and purchased $499.7K worth of RAD shares.

Whiting Petroleum is down -4.76% in midday trading to $6.81. Shares opened today at $7.15. The company has a 52-week low of $4.29 and a 52-week high of $30.94. On the Street’s front, the average 12-month analyst price target for the stock is $8.36, marking a 16.92% potential upside from current levels. In a report issued on December 6, Barclays analyst William S. Thompson maintained a Hold rating on WLL, with a price target of $5.00, which implies a downside of 30% from current levels. Separately, on December 2, R. F. Lafferty’s Jaime Perez maintained a Buy rating on the stock and has a price target of $12.00.

Exelixis is down -4.58% in midday trading to $18.13. Shares opened today at $19.00. The company has a 52-week low of $15.02 and a 52-week high of $25.31. On the Street’s front, the average 12-month analyst price target for the stock is $24.33, marking a 28.05% potential upside from current levels. In a report issued on December 17, Morgan Stanley analyst Jeffrey Hung maintained a Hold rating on EXEL, with a price target of $20.00, which represents a potential upside of 5% from where the stock is currently trading. Separately, on December 13, Needham’s Chad Messer maintained a Buy rating on the stock and has a price target of $30.00. In the last 30 days, insiders have sold $462K worth of EXEL shares.

See today’s analyst top recommended stocks >>

Agios Pharma is down -4.45% in midday trading to $48.48. Shares opened today at $50.74. The company has a 52-week low of $28.36 and a 52-week high of $68.94. On the Street’s front, the average 12-month analyst price target for the stock is $61.13, marking a 20.48% potential upside from current levels. In a report issued on December 17, Piper Jaffray analyst Tyler Van Buren maintained a Buy rating on AGIO, with a price target of $70.00, which implies an upside of 38% from current levels. Separately, on October 21, Goldman Sachs’ Salveen Richter maintained a Hold rating on the stock and has a price target of $40.00. Over the last 3 months, the insider sentiment on Agios Pharma has been positive based on 29 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

American Airlines is down -4.44% in midday trading to $28.44. Shares opened today at $29.76. The company has a 52-week low of $24.23 and a 52-week high of $37.23. On the Street’s front, the average 12-month analyst price target for the stock is $33.25, marking a 11.73% potential upside from current levels. In a report issued on November 12, UBS analyst Myles Walton initiated coverage with a Sell rating on AAL and a price target of $27.00, which reflects a potential downside of -9% from last closing price. Separately, on October 28, J.P. Morgan’s Jamie Baker maintained a Buy rating on the stock and has a price target of $43.00. Over the last 3 months, the insider sentiment on American Airlines has been positive based on 52 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Trending Stocks Based on Insider Activity >>